Travere Therapeutics TVTX
NASDAQ TVTX
$52.44 -0.14 (-0.27%)
As of: Oct 22, 2026 · 3:59 PM EDT

Travere Therapeutics (TVTX) Preferred Shares (2012)

Updated

Travere Therapeutics (TVTX) reported Preferred Shares of $1.00 for Q3 2012.

Analysis

Travere Therapeutics (TVTX) Preferred Shares (2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Travere Therapeutics 4.88 Bn 4.48 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Feb 29, 2012 1.00
API Access

Travere Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=TVTX&period=max&api_key=YOUR_API_KEY